Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

计划入组 30 人 · 首次发布于 2025 年 5 月 2 日

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

计划入组 1,200 人 · 首次发布于 2020 年 6 月 5 日

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

计划入组 177 人 · 首次发布于 2026 年 8 月 12 日

SEQ-9

SEQ-1274

SEQ-400

JOHN SAPP

United States

SWISS CAPS AG

Switzerland

NAPP PHARMACEUTICALS LIMITED

United Kingdom

Novel Cell-Free DNA Assays Enhance MRD Detection in Lymphoma Subtypes

Foresight Diagnostics and Roche Resolve Patent Dispute with PhasED-Seq Licensing Agreement for Non-Hodgkin's Lymphoma Diagnostics

Ultrasensitive DNA Detection Shows Promise in B-Cell Lymphoma Remission Assessment